CD44 and cancer: Delivery of miR-34a into cancer cells or animal models could promote cell proliferation, invasion and metastasis, which was mediated by targeted inhibition of its target genes, including CD44 [18] and MMPs (e.g. MMP9, MMP14, MMP2) [19, 20].